Funds holding R&G PharmaStudies Co Ltd
ISIN CNE100005K44 · China
- Fund holders
- 2
- Of which ETFs
- 2 0 other funds
- Value held
- 326K $
2 tracked funds declare this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS | 23,200 | 230.6K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 9,600 | 95.4K $ | 0.01 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 0.01 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 2 | 0 | 32,800 | 0.0 % |
| 2026Q1 | 2 | 0 | 32,800 | +0.6 % |
| 2025Q4 | 2 | 0 | 32,600 | 0.0 % |
| 2025Q3 | 2 | 0 | 32,600 | 0.0 % |
| 2025Q2 | 2 | 0 | 32,600 | 0.0 % |
| 2025Q1 | 2 | 0 | 32,600 | -0.6 % |
| 2024Q4 | 2 | 0 | 32,800 | 0.0 % |
| 2024Q3 | 2 | 0 | 32,800 | -12.3 % |
| 2024Q2 | 2 | 0 | 37,400 | 0.0 % |
| 2024Q1 | 2 | 0 | 37,400 | 0.0 % |
| 2023Q4 | 2 | 37,400 |
Cite this page
Titelia. "Funds holding R&G PharmaStudies Co Ltd". https://titelia.com/en/stocks/r-g-pharmastudies-co-ltd-CNE100005K44